menu search

Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann

Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...

November 3, 2023, 10:00 am

Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting

SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...

October 31, 2023, 9:05 am

Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting

SAN CARLOS, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...

September 27, 2023, 4:01 pm

Iovance biotherapeutics to present at 2023 wells fargo healthcare conference

SAN CARLOS, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, d...

September 7, 2023, 11:31 am

Iovance biotherapeutics to present at 2023 wells fargo healthcare conference

SAN CARLOS, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...

September 7, 2023, 7:31 am

Iovance biotherapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

SAN CARLOS, Calif., July 21, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...

July 21, 2023, 9:34 pm

Turnstone biologics corp. announces pricing of upsized initial public offering

SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotec...

July 21, 2023, 6:15 am

Iovance biotherapeutics to host virtual roundtable with key opinion leaders to discuss melanoma treatment landscape

Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET SAN CARLOS, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (...

June 20, 2023, 11:01 am

Iovance: capturing a lucrative market

Iovance Biotherapeutics, Inc. is poised to complete its rolling Biologic License Application for advanced melanoma this quarter. The recent Proleukin ...

February 1, 2023, 6:33 pm

Why iovance biotherapeutics is crashing today

The FDA is asking the drug development outfit for more information regarding its tumor-infiltrating lymphocyte...

November 18, 2022, 1:06 pm

Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...

March 9, 2022, 8:21 am


Search within

Pages Search Results: